Search
Levetiracetam
go.drugbank.com/drugs/DB01202ApprovedInvestigationalLevetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically un...
Categories: P-glycoprotein substratesProducts: LEVETIRACETAM 100MG+3 NET, LEVETIRACETAM HEU 250 NETPeracetic acid
go.drugbank.com/drugs/DB14556InvestigationalA liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.
Products: Pu Us Pure, Pu Us LemonGlycopyrronium
go.drugbank.com/drugs/DB00986ApprovedInvestigationalVet approvedGlycopyrronium, also known as NVA237 or glycopyrrolate, is a racemic mixture of two enantiomers. They are both quaternary ammonium compounds and long acting muscarinic antagonists. It is one of the most commonly prescribed anticholinergi...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesProducts: Glyrx-PF, GLYCO-PRisperidone
go.drugbank.com/drugs/DB00734ApprovedInvestigationalRisperidone is a second-generation antipsychotic (SGA) medication used in the treatment of a number of mood and mental health conditions including schizophrenia and bipolar disorder. It is one of the most widely used SGAs. Paliperidone, ...
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: RISPERIDON HEU 1MG NET, RISPERIDON HEU 2MG NETOlopatadine
go.drugbank.com/drugs/DB00768ApprovedOlopatadine is a selective histamine H1 antagonist and mast cell stabilizer that works by attenuating inflammatory and allergic reactions. It is a structural analog of doxepin, which has a minimal anti-allergic activity. Olopatadine work...
Categories: Cytochrome P-450 Substrates, P-glycoprotein substratesProducts: OLODINA PF®, OLOFTAL PF®Ketoprofen
go.drugbank.com/drugs/DB01009ApprovedInvestigationalVet approvedKetoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 InhibitorsProducts: MİVELİN PR 200 MG KAPSÜL , 10 ADET, MİVELİN PR 200 MG KAPSÜL , 20 ADETOlanzapine
go.drugbank.com/drugs/DB00334ApprovedInvestigationalOlanzapine is a thienobenzodiazepine derivative and an atypical or second-generation antipsychotic agent. Its chemical structure contains a thieno[2,3-b][1,5]benzodiazepine core, and has a methyl group attached to the piperazine ring. Th...
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: OLANZAPIN HEU 5 SMT NET, OLANZAPIN HEU 10 SMT NETTrofinetide
go.drugbank.com/drugs/DB06045Approved, making trofinetide the first and only treatment approved for Rett syndrome in the European Union. … [A258438] Trofinetide was approved by the FDA on March 10, 2023, for the treatment of Rett syndrome,[L45718,L45748] which is an X-linked neurodevelopmental disorder characterized by a range of cognitive
Categories: P-glycoprotein inhibitors, Cytochrome P-450 CYP3A InhibitorsPaclitaxel
go.drugbank.com/drugs/DB01229ApprovedInvestigationalVet approvedPaclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree whi...
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesProducts: PAXUS PM (30 MG), PAXUS PM (100 MG)Nebivolol
go.drugbank.com/drugs/DB04861ApprovedInvestigationalNebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity. Treatment with nebivolol leads to a greater decrease in systolic and di...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesProducts: NEBIVOLOL HEUMANN 5MG NET